Cramer's 10 things to watch in the market on Tuesday: Dow, iPhones, JNJ

Estimated read time: 6 min

An Apple store on Nanjing Road Pedestrian Street in Shanghai, China on December 16, 2022.

CFOTO | Edition of the future | Getty Images

My top 10 things to watch Tuesday, January 31

1. Will the outperformance of speculative stocks continue? The worst market performers in 2022 – including crypto, SPAC and cloud software stocks – are among the biggest gainers in this year’s rally. Stay away. As I wrote on Sunday, I see this as a turning point in mature stocks aligned with the so-called old or real economy.

2. You’ll find many of these real economy stocks, or workhorses, in the Dow Jones. We have reviewed its 30 members to show how they match the names we have in the Trust.

3. According to UBS, iPhone sales, or sales to end users, fell 12% in the fourth quarter of 2022 due to supply chain disruptions; it maintained a buy rating on Apple (AAPL). Let’s assume it’s consensus now, which would put the stock at around $130.

4. Apple is one of 9 Club stocks to report quarterly results on Thursday. The list includes the industrial conglomerate Honeywell International (HON), Starbucks (SBUX) and tech giant Alphabet (GOOGL). These reports and conference calls should provide excellent information on the state of the US economy. Here’s our breakdown of Thursday’s schedule, including analyst estimates for earnings per share and revenue.

5. McDonald’s (MCD) posted very strong numbers, beating earnings and revenue estimates. But the market doesn’t like it, which is stupid. Market share fell more than 1% in pre-market.

6. Johnson & Johnson (JNJ) won’t be able to use the bankruptcy trick to offload tens of thousands of lawsuits over its talc products. A U.S. appeals court has ruled the healthcare conglomerate improperly placed a subsidiary in Chapter 11, even though it was not in financial difficulty. The mess remains. The company has already paid $3 billion.

7. Humira’s days as a top-selling drug come to an end today as Amgen (AMGN) begins selling an almost identical organic product. AbbVie (ABBV), which makes the injectable treatment for rheumatoid arthritis, expects a 45% drop in sales in 2023. This is mostly priced into the stock, which is selling at a low multiple.

8. caterpillar (CAT) sales rose 20% in the fourth quarter of 2022 on strong demand for its construction equipment. It’s been a really great quarter, but equities are being treated badly by the market.

9. Deutsche Bank sees improved leadership and efficiency at disney (SAY). New CEO Robert Iger will use his own plan, better integrate Hulu.

ten. The incredible decline of natural gas is something to celebrate as it is used in so many things. Prices fell to their lowest level in nearly two years on Monday, thanks to an unusually warm winter.

(To see here for a full list of Jim Cramer’s Charitable Trust actions.)

As a CNBC Investing Club subscriber with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust’s portfolio. If Jim talked about a stock on CNBC TV, he waits 72 hours after issuing the trade alert before executing the trade.

THE ABOVE INVESTMENT CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY, AS WELL AS OUR DISCLAIMER. NO OBLIGATION OR FIDUCIARY DUTY EXISTS, OR IS CREATED BY YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTMENT CLUB. NO SPECIFIC RESULTS OR PROFITS ARE GUARANTEED.

Post a Comment

Cookie Consent
We serve cookies on this site to analyze traffic, remember your preferences, and optimize your experience.
Oops!
It seems there is something wrong with your internet connection. Please connect to the internet and start browsing again.
AdBlock Detected!
We have detected that you are using adblocking plugin in your browser.
The revenue we earn by the advertisements is used to manage this website, we request you to whitelist our website in your adblocking plugin.
Site is Blocked
Sorry! This site is not available in your country.